echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Announcement on the Implementation of Electronic Declaration of Drug Registration Applications (Draft for Solicitation of Comments)

    Announcement on the Implementation of Electronic Declaration of Drug Registration Applications (Draft for Solicitation of Comments)

    • Last Update: 2022-11-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In order to implement the reform requirements of "decentralization, management and service", further optimize the business environment, reduce the burden on enterprises, and promote the electronic declaration of drug registration applications, the State Food and Drug Administration organized and drafted the "Announcement on the Implementation of Electronic Application for Drug Registration (Draft for Comments)" and the "Notice on Relevant Requirements for Electronic Declaration of Drug Registration Applications (Draft for Comments)", "Technical Requirements for Electronic CD-ROMs for Application Materials (Draft for Comments)", "Electronic File Structure of Drug Registration Applications (Draft for Comments)" and "Letter of Commitment (Draft for Comments)" (see annex), which is now open to the public for comments
    .
    Please give feedback to our office
    before November 20, 2022.
    Contact number: 010-85242409 Email: zhongwch@cde.
    org.
    cn Attachments: 1.
    Announcement on the implementation of electronic declaration of drug registration applications (Draft for Comments).
    2.
    Notice on the requirements for electronic declaration of drug registration applications (Draft for Comments) 3.
    Technical Requirements for Electronic CD-ROMs for Application Materials (Draft for Comments) 4.
    Electronic File Structure of Drug Registration Application (Draft for Solicitation of Comments)5.
    Letter of Commitment (Draft for Solicitation of Comments) 6.
    Feedback Form Comprehensive Department of the State Food and Drug Administration November 4, 2022  
    ={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"Share to:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
    appendChild(createElement('script')).
    src='http://bdimg.
    share.
    baidu.
    com/static/api/js/share.
    js?v=89860593.
    js?cdnversion='+~(-new Date()/36e5)];
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.